Fischer Medical Ventures Limited (FISCHER) Share Price
NSE · Healthcare · Medical Devices · ISIN INE771F01041
Key metrics
- Market Cap
- ₹2,414 Cr
- P/E Ratio
- 82.02
- EPS
- 0.43
- Book Value
- 5.88
- P/B Ratio
- 6.16
- ROE
- 8.05%
- ROCE
- 8.15%
- Debt / Equity
- 0.28
- Net Margin
- 10.05%
- Revenue Growth
- 178.75%
- Profit Growth
- 2,468.04%
- Dividend Yield
- 0.01%
- 52W High
- ₹124.70
- 52W Low
- ₹31.05
- Market Cap Band
- small cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Fischer Medical Ventures Limited
Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.
- Headquarters
- Chennai, India
- Promoter Holding
- 77.25%
The full Fischer Medical Ventures Limited analysis
Create a free account to open the complete FISCHER deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.